Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia

Human Gene Therapy

Volumn 7, Issue 5, 1996, Pages 647-653

  Judde, Jean Gabriel ^a   Spangler, Gordon ^a   Magrath, Ian ^a   Bhatia, Kishor ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYTOSINE DEAMINASE; FLUCYTOSINE; LUCIFERASE; THYMIDINE KINASE; TRANSACTIVATOR PROTEIN; VIRUS ANTIGEN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ASSAY; EPSTEIN BARR VIRUS; FIBROBLAST CULTURE; GENE EXPRESSION; GENE TARGETING; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; MOLECULAR CLONING; PLASMID; PROMOTER REGION; RECOMBINANT GENE; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS;

EID: 0029963071     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.5-647     Document Type: Article

References (35)

1. AUSTIN, H.A., and HUBER, B.E. (1993). A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 43, 380-387.
2. BUSSON, P., BRAHAM, K., GANEM, G., THOMAS, F., GRAUSZ, D., LIPINSKI, M., WAKASUGI, H., and TURSZ, T. (1987). Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha. Proc. Natl. Acad. Sci. USA 84, 6262-6266.
3. CAO, S., RUSTUM, Y.M., and SPECTOR, T. (1994). 5-Ethynyluracil (776C85): Modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma. Cancer Res. 54, 1507-1510.
4. FLEMING, R.A., MILANO, G., THYSS, A., ETIENNE, M.C., RENEE, N., SCHNEIDER, M., and DEMARD, F. (1992). Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res. 52, 2899-2902.
5. GUTIERREZ, M.I., BHATIA, K., and MAGRATH, I. (1993). Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Leuk. Res. 17, 285-289.
6. HARN, H.J., CHANG, J.Y., WANG, M.W., HO, L.I., LEE, H.S., CHIANG, J.H., and LEE, W.H. (1995). Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum. Pathol. 26, 267-271.
7. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039-8043.
8. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
9. JAIN, V., JUDDE, J.-G., MAX, E.E., and MAGRATH, I.T. (1993). Variable IgH enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. J. Immunol. 12, 5418-5428.
10. KIRCHMAIER, A.L., and SUGDEN, B. (1995). Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol. 69, 1280-1283.
11. LABRECQUE, L.G., BARNES, D.M., FENTIMAN, I.S., and GRIFFIN, B.E. (1995). Epstein-Barr virus in epithelial cell tumors: A breast cancer study. Cancer Res. 55, 39-45.
12. LAUFMAN, L.R., KRZECZOWSKI, K.A., ROACH, R., and SEGAL, M. (1987). Leucovorin plus 5-fluorouracil: An effective treatment for metastatic colon cancer. J. Clin. Oncol. 5, 1394-1400.
13. LUCKOW, B., and SCHUETZ, G. (1987). CAT constructions with multiple unique restriction sites for functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5490.
14. MAGRATH, I., JAIN, V., and BHATIA, K. (1992). Epstein-Barr virus and Burkitt's lymphoma. Semin. Cancer Biol. 3, 285-295.
15. MAGRATH, I., BHATIA, K., and HUBER, B. (1994). Genetic intervention in the control of neoplasia. In Developmental Biology and Cancer. (CRC Press, Boca Raton, FL) pp. 479-523.
16. MANOME, Y., ABE, M., HAGEN, M.F., FINE, H.A., and KUFE, D.W. (1994). Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res. 54, 5408-5413.
17. McCLAIN, K.L., LEACH, C.T., JENSON, H.B., JOSHI, V.V., POLLOCK, B.H., PARMLEY, R.T., DICARLO, F.J., CHADWICK, E.G., and MURPHY, S.B. (1995). Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS [see comments]. N. Engl. J. Med. 332, 12-18.
18. MIYAO, Y., SHIMIZU, K., MORIUCHI, S., YAMADA, M., NAKAHIRA, K., NAKAJIMA, K., NAKAO, J., KURIYAMA, S., TSUJH, T., MIKOSHIBA, K., and ET AL. (1993). Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J. Neurosci. Res. 36, 472-479.
19. MORGENSTERN, J.P., and LAND, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
20. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
21. MULLEN, C.A., COALE, M.M., LOWE, R., and BLAESE, R.M. (1994). Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503-1506.
22. NAGUIB, F.N., EL-KOUNI, K.M., and CHA, S. (1985). Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res. 45, 5405-5412.
23. PLAUTZ, G.E., YANG, Z.Y., WU, B.Y., GAO, X., HUANG, L., and NABEL, G.J. (1993). Immunotherapy of malignancy by in vivo gene transfer into tumors [see comments]. Proc. Natl. Acad. Sci. USA 90, 4645-4649.
24. PURTILO, D.T., STROBACH, R.S., OKANO, M., and DAVIS, J.R. (1992). Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest. 67, 5-23.
25. REISMAN, D., and SUGDEN, B. (1986). Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen. 1. Mol. Cell. Biol. 6, 3828-3846.
26. REISMAN, D., YATES, J., and SUGDEN, B. (1985). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5, 1822-1832.
27. ROGERS, R.P., STROMINGER, J.L., and SPECK, S.H. (1992). Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. Adv. Cancer Res. 58, 1-26.
28. ROSENTHAL, F.M., CRONIN, K., BANNERJI, R., GOLDE, D.W., and GANSBACHER, B. (1994). Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs. Blood 83, 1289-1298.
29. SAMOSZUK, M., and RAVEL, J. (1991). Frequent detection of Epstein-Barr viral deoxyribonucleic acid and absence of cytomegalovirus deoxyribonucleic acid in Hodgkin's disease and acquired immunodeficiency syndrome-related Hodgkin's disease. Lab Invest. 65, 631-636.
30. SHEPARD, H.M., LEWIS, G.D., SARUP, J.C., FENDLY, B.M., MANEVAL, D., MORDENTI, J., FIGARI, I., KOTTS, C.E., PALLADINO, M.J., ULLRICH, A., and SLAMON, D. (1991). Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. J. Clin. Immunol. 11, 117-127.
31. SUZUSHIMA, H., ASOU, N., FUJIMOTO, T., NISHIMURA, S., OKUBO, T., YAMASAKI, H., OSATO, M., MATSUOKA, M., TSUKAMOTO, A., TAKAI, K., KAWANO, F., and TAKATSUKI, K. (1995). Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood 85, 480-486.
32. UCKUN, F.M., EVANS, W.E., FORSYTH, C.J., WADDICK, K.G., AHLGREN, L.T., CHELSTROM, L.M., BURKHARDT, A., BOLEN, J., and MYERS, D.E. (1995). Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267, 886-891.
33. WYSOKENSKI, D.A., and YATES, J.L. (1989). Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 63, 2657-2666.
34. YATES, J.L., WARREN, N., and SUGDEN, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in a variety of mammalian cells. Nature 272, 373-375.
35. ZHANG, S., and NONOYAMA, M. (1994). The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family. Proc. Natl. Acad. Sci. 91, 2843-2847.